Rheumatoid Arthritis Clinical Trials

Showing 4961-4980 of 35,946 trials

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

NCT06414434

This study is testing two different doses of BTX-A51 to determine if it is safe and tolerable in participants with liposarcoma with MDM2 amplification, myxoid liposarcoma, and CIC-rearranged sarcoma. The name of the study drug used in this research study is: -BTX-A51 (a type of kinase inhibitor)

LiposarcomaRecurrent LiposarcomaMetastatic Liposarcoma+4 more

Michael Wagner, MD24 participantsStarted Sep 2024

Boston, Massachusetts, United States • Boston, Massachusetts, United States

RECRUITING

FebriDx® Pediatric Validation Study

NCT07211997

The primary objective of this study is to determine performance characteristics of the FebriDx® test in differentiating bacterial from non-bacterial etiology among febrile pediatric patients (2-11 years) presenting to the emergency department, urgent care center or primary care office with a suspected acute respiratory tract infection.

Acute Respiratory Infections (ARIs)

Lumos Diagnostics800 participantsStarted Oct 2025

Colton, California, United States • Clearwater, Florida, United States • Lutz, Florida, United States +7 more locations

COMPLETEDPhase 1

Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men

NCT02754687

The long term objective is to develop a new male hormone 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) as a male hormonal contraceptive.

Healthy MenMale Contraception

Premier Research12 participantsStarted Jul 2016

Torrance, California, United States • Seattle, Washington, United States

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

FebriDx® Pediatric Validation Study

Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men

Related Searches

Designing a Mobile App to Support Academic Success for Student Veterans

REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center

Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

Healthy Hydration Pilot in Elementary Schools

Tailored Exercise Training Study Among Adults With HFpEF

Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)

CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients

Improving Walking in Peripheral Artery Disease

Daratumumab in HLA Desensitization Prior to Transplantation

Studies of Brain and Body Interaction

MDR - Biomet Cannulated Screws

MDR - Comprehensive Primary/Micro Stem & Versa-Dial Ti Humeral Head

OCS Heart Perfusion Post-Approval Registry

Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty

Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD